Grants per year
- 100 - 119 out of 119 results
Search results
-
Finished
Prot#211-00/FOS 530: Rndmzd, Dbl-Blind, Dbl-Dummy, Prll-Grp, Mlticntr Stdy to Eval & Comp Effects of 1x Wkly Alendronate & Risedronate on Bone Mineral Density in Postmenopausal Women w/Osteoporosis (FACT - FOSAMAX® ACTONEL® Comparison Trial)
Schnitzer, T. J. (PD/PI)
NorthShore University HealthSystem Research Institute, Merck & Co., Inc.
8/23/04 → 12/31/05
Project: Research project
-
Prot# CZOL446M2308: Randomized, Multicenter, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy & Safety of Intravenous Zoledronic Acid 5mg Annually Compared to Oral Alendronate 70mg Weekly for the Treatment of Osteoporosis in Men
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
7/2/04 → 6/20/08
Project: Research project
-
Prot# CZOL446M2308: Randomized, Multicenter, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy & Safety of Intravenous Zoledronic Acid 5mg Annually Compared to Oral Alendronate 70mg Weekly for the Treatment of Osteoporosis in Men
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
7/2/04 → 6/20/08
Project: Research project
-
Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis
Schnitzer, T. J. (PD/PI)
Parexel, Novartis Pharmaceuticals Corporation
4/15/04 → 4/27/07
Project: Research project
-
Prot# WL-1001-05-04: An Open Label Multicenter Study Evaluating the Safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis of the Knee(s)
Schnitzer, T. J. (PD/PI)
3/23/04 → 12/31/06
Project: Research project
-
Prot# WL-1001-05-04: An Open Label Multicenter Study Evaluating the Safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis of the Knee(s)
Schnitzer, T. J. (PD/PI)
3/23/04 → 12/31/06
Project: Research project
-
Prot# 211-10/FOS530: 12-Month Extension to: Rndmzd, Dbl-Blnd, Dbl-Dmmy, Prll-Grp, Mltcntr Study to Evaluate & Compare Effects of 1x Wkly Alendronate & Risedronate on Bone Mineral Density in Postmenopausal Women w/Osteoporosis (FACT - OSAMAX® ACTONAL® Comp
Schnitzer, T. J. (PD/PI)
2/20/04 → 12/11/06
Project: Research project
-
Prot# 211-10/FOS530: 12-Month Extension to: Rndmzd, Dbl-Blnd, Dbl-Dmmy, Prll-Grp, Mltcntr Study to Evaluate & Compare Effects of 1x Wkly Alendronate & Risedronate on Bone Mineral Density in Postmenopausal Women w/Osteoporosis (FACT - OSAMAX® ACTONAL® Comp
Schnitzer, T. J. (PD/PI)
2/20/04 → 12/11/06
Project: Research project
-
Prot# CCOX189A2360E1: 39-Wk, Opn-Lbl, Ext'n to CCOX189A2360, a 13-Wk, Mlticntr, Rndmzd, Dbl-Bld, Dbl-Dummy, Plcbo-Cntrld, Prl'l-Trial of 2 Different Dose Regimens of Lumiracoxib(100mg od & 200mg od Initial Dose for 2 wks Flw'd by 100mg od) in Pt's w/ Prim
Schnitzer, T. J. (PD/PI)
Novartis Pharmaceuticals Corporation
1/1/04 → 11/27/06
Project: Research project
-
Prot# CCOX189A2360E1: 39-Wk, Opn-Lbl, Ext'n to CCOX189A2360, a 13-Wk, Mlticntr, Rndmzd, Dbl-Bld, Dbl-Dummy, Plcbo-Cntrld, Prl'l-Trial of 2 Different Dose Regimens of Lumiracoxib(100mg od & 200mg od Initial Dose for 2 wks Flw'd by 100mg od) in Pt's w/ Prim
Schnitzer, T. J. (PD/PI)
Novartis Pharmaceuticals Corporation
1/1/04 → 11/27/06
Project: Research project
-
Prot# 227-00: 15-Wk, Dbl-Blnd, Rndmzd, Active-Cntrlld, Mltcntr Study w/ 24-Wk Extension to Evaluate the Safety, Tolerability, & Efficacy of Alendronate 70-mg Plus Vitamin D3 2800 IU Combination Tablet in Men & Postmenopausal Women w/ Osteoporosis
Schnitzer, T. J. (PD/PI)
11/12/03 → 2/2/07
Project: Research project
-
Prot# 227-00: 15-Wk, Dbl-Blnd, Rndmzd, Active-Cntrlld, Mltcntr Study w/ 24-Wk Extension to Evaluate the Safety, Tolerability, & Efficacy of Alendronate 70-mg Plus Vitamin D3 2800 IU Combination Tablet in Men & Postmenopausal Women w/ Osteoporosis
Schnitzer, T. J. (PD/PI)
11/12/03 → 2/2/07
Project: Research project
-
Prot# SP-NON-0010: Phase II Study on Analgesic Efficacy, Safety & Tolerability of AR-P900758XX: A 6 Week, Rndmzd, Dbl-Bld, Placebo-Controlled, Dose-Finding, Mltctr Study Comparing AR-P900758XX w/ Vioxx® & w/ Naproxen in Subjects w/ Osteoarthritis of Knee
Schnitzer, T. J. (PD/PI)
Rheumatology Research International (RRI), AstraZeneca Pharmaceuticals LP
3/11/02 → 5/16/07
Project: Research project
-
Prot# CZOL446H2301: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
Schnitzer, T. J. (PD/PI)
PPD Development, Novartis Pharmaceuticals Corporation
1/11/02 → 8/1/06
Project: Research project